Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs

Immunological Reviews

Volumn 184, Issue , 2001, Pages 275-285

  Soares, Miguel P ^a   Brouard, Sophie ^a   Smith, R Neal ^b   Bach, Fritz H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTITHROMBIN III; BILIRUBIN; CARBON MONOXIDE; CD39 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYCLOSPORIN A; CYTOKINE; FAS ANTIGEN; FERRITIN; GAMMA INTERFERON; HEME OXYGENASE 1; HEMOGLOBIN; HEPARAN SULFATE; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; MYOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VON WILLEBRAND FACTOR; ZINC FINGER PROTEIN;

APOPTOSIS; DOWN REGULATION; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CARBON MONOXIDE; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MEMBRANE PROTEINS;

EID: 0035707492     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065x.2001.1840124.x     Document Type: Review

References (92)

1. Present experiences in a series of 26 ABO-incompatible living donor renal allografts
2. Renal transplant in a patient with major donor-recepient blood group incompatibility: Reversal of acute rejection by the use of modified plasmapheresis
3. New directions for organ transplantation
4. ABO-incompatible heart transplantation in infants
5. Accommodation: A working paradigm for progressing toward clinical discordant xenografting
6. Accommodation
7. Protective responses of endothelial cells
8. Delayed xenograft rejection
9. Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts
10. Pathogenesis of and potential therapies for delayed xenograft rejection
11. Endothelial cell activation and thromboregulation during xenograft rejection
12. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: Analysis using adoptive and passive transfer
13. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection
14. Long-term survival of hamster hearts in presensitized rats
15. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment
16. Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype
17. Both concordant and discordant heart xenografts are rejected by athymic (nude) rats with the same tempo as in T cell competent animals
18. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection
19. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses
20. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production
21. Protective genes expressed in endothelial cells - A regulatory response to injury
22. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naïve xenografts
23. Expression of heme oxygenase-1 (HO-1) can determine cardiac xenograft survival
24. Endothelial cells in physiology and in the pathophysiology of vascular disorders
25. Negative regulation of inflammation by Fas ligand expression on the vascular endothelium
26. The role of endothelial cells in inflammation
27. Cytokine regulation of endothelial cell function - From molecular level to the bedside
28. Von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells
29. Endothelial cell memory of inflammatory stimulation - Human venular endothelial cells store interleukin 8 in Weibel-Palade bodies
30. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells
31. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection
32. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
33. Loss of ATP diphosphohydrolase activity with endothelial cell activation
34. Transient perturbation of endothelial integrity induced by natural antibodies and complement
35. High-level expression of functional human thrombomodulin in cultured porcine aortic endothelial cells
36. Adenovirus mediated expression of a dominant negative mutant of p65/RelA Inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis
37. Modification of vascular responses in xenotransplantation: Inflammation and apoptosis
38. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress
39. Inhibition of the RelA(p65) NF-κB subunit by Egr-1
40. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein
41. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow
42. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
43. Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation - A means of evaluating the role of endothelial cell activation in xenograft rejection
44. Overexpression of A1, an NF-κB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation
45. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1
46. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1
47. IAP family proteins - Suppressors of apoptosis
48. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
49. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells
50. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells front tumor necrosis factor α-reduced apoptosis
51. NF-κB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells
52. Suppression of TNF-α-induced apoptosis by NF-κB
53. TNF- and cancer therapy-induced apoptosis - Potentiation by inhibition of NF-κB
54. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
55. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism
56. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice
57. Overview of HO-1 in inflammatory pathologies
58. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury
59. The heme oxygenase system: A regulator of second messenger gases
60. Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase
61. The heme synthesis and degradation pathways: Role in oxidant sensitivity - Heme oxygenase has both pro- and antioxidant properties
62. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron
63. Ferritin: A cytoprotective antioxidant strategem of endothelium
64. Heme oxygenase mediates an adaptive response to oxidative stress in human skin fibroblasts
65. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse to rat cardiac transplants
66. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage
67. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: Protective effect against heme and hemoglobin toxicity
68. Ferritins - Molecular properties, iron storage function and cellular regulation
69. Basis of guanylate cyclase activation by carbon monoxide
70. Carbon monoxide mediates anti-inflammatory effects via the mitogen activated protein kinase pathway
71. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis
72. Heme oxygenase-1 protects against vascular constriction and proliferation
73. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide
74. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis
75. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1
76. Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblast
77. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia
78. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase
79. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells
80. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP
81. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion
82. Carbon monoxide provides protection against hyperoxic lung injury
83. Lipopolysaccharide induces disseminated endothelial cell apoptosis requiring ceramide
84. Apoptotic vascular endothelial cells become procoagulant
85. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
86. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets
87. Haem oxygenase-1 prevents cell death by regulating cellular iron
88. The p38 signal transduction pathway: Activation and function
89. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α
90. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
91. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
92. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase